Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 9
Submit an article Journal homepage
74
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Primary Omental Gamma/Delta T-Cell Lymphoma Involving the Central Nervous System

Y Harada The Third Department of Internal Medicine, Tokyo Medical University, Tokyo, JapanCorrespondence[email protected]
,
S Kato Department of Diagnostic Pathology, Tokyo Medical University, Tokyo, Japan
,
H Komiya The Third Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
,
T Shirota Department of Diagnostic Pathology, Tokyo Medical University, Tokyo, Japan
,
K Mukai The Third Department of Internal Medicine, Tokyo Medical University, Tokyo, Japan
&
T Hayashi Department of Diagnostic Pathology, Tokyo Medical University, Tokyo, Japan
Pages 1947-1950 | Received 19 Dec 2003, Published online: 03 Aug 2009

References

  • Glazer, H.S., Lee, J.K., Balfe, D.M., Mauro, M.A., Griffith, R. and Sagel, S.S. (1983) "Non-Hodgkin lymphoma: computed tomo-graphic demonstration of unusual extranodal involvement", Radi-ology, 149, 211–217.
  • Farcet, J.P., Gaulard, P., Marolleau, J.P., Le Couedic, J.P., Henni, T., Gourdin, M.F., et al. (1990) "Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta", Blood, 75, 2213–2219.
  • Arnulf, B., Copie-Bergman, C., Delfau-Larue, M.H., Lavergne-Slove, A., Bosq, J., Wechsler, J., et al. (1998) "Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization", Blood, 91, 1723–1731.
  • Yamaguchi, M., Ohno, T., Nakamine, H., Oka, K., Matsuzuka, F., Miwa, H., et al. (1999) "Gamma delta T-cell lymphoma: a clinicopathologic study of 6 cases including extrahepatosplenic type", International Journal of Hematology, 69, 186 — 195.
  • Katoh, A., Ohshima, K., Kanda, M., Haraoka, S., Sugihara, M., Suzumiya, J., et al. (2000) "Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/ delta T cell and natural killer cells", Leukemia and Lymphoma, 39, 97–111.
  • Weidmann, E. (2000) "Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990", Leukemia, 14, 991–997.
  • Chim, CS., Lam, C.C., Nicholls, J.M., Ooi, G.C. and Kwong, Y.L. (2002) "Unusual hematologic malignancies. Case 3. CNS involve-ment in CD56-positive intestinal gamma/delta T-cell lymphoma", Journal of Clinical Oncology, 20, 3742— 3744.
  • Lanier, L.L., Chang, C., Azuma, M., Ruitenberg, J.J., Hemperly, J.J. and Phillips, J.H. (1991) "Molecular and functional analysis of human natural killer cell-associated neural cell adhesion molecule (N-CAM/CD56)", Journal of Immunology, 146, 4421 — 4426.
  • Chan, J.K., Sin, V.C., Wong, K.F., Ng, CS., Tsang, WY., Chan, C.H., et al. (1997) "Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm", Blood, 89, 4501 —4513.
  • Kwong, Y.L., Chan, AC., Liang, R., Chiang, A.K., Chim, CS., Chan, T.K., et al. (1997) "CD56 + NK lymphomas: clinicopatho-logical features and prognosis", British Journal of Haematology, 97, 821 — 829.
  • Mocellin, S., Provenzano, M., Lise, M., Nitti, D. and Rossi, C.R. (2003) "Increased TIA-1 gene expression in the tumor microenvir-onment after locoregional administration of tumor necrosis factor-a to patients with soft tissue limb sarcoma", International Journal of Cancer, 107, 317–322.
  • Trapani, J.A. and Sutton, V.R. (2003) "Granzyme B: pro-apoptotic, antiviral and antitumor functions", Current Opinion in Immunology, 15, 533 — 543.
  • Belhadj, K., Reyes, F., Farcet, J.-P., Tilly, H., Bastard, C Angonin, R., et al. (2003) "Hepatosplenic y T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients", Blood, 102, 4261–4269.
  • Cooke, C.B., Krenacs, L., Stetler-Stevenson, M., Greiner, T.C., Raffeld, M., Kingma, DW., et al. (1996) "Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic y5 T-cell origin", Blood, 88, 4265–4274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.